Weight-Loss Drugs Like Wegovy Could Be Mass-Produced for Just $3 Per Month, Study Finds
New research indicates that weight-loss medications based on semaglutide (such as Wegovy and Ozempic) could be mass-produced for as little as $3 (approximately £2.35) per month for the injectable form. Currently, these drugs cost around $200 monthly in the United States and £120 monthly in the United Kingdom. The study, based on shipment records of key ingredients from 2024-2025, employs a methodology previously used to accurately predict prices of generic medicines for HIV, hepatitis C, and certain cancer drugs.











